Latest news with #Notetaker
Yahoo
05-05-2025
- Health
- Yahoo
Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry
CHICAGO, May 05, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an AI-powered clinical assistant to aid psychiatrists in generating progress notes. Notetaker, which is available in Tempus Hub, ambiently records patient sessions to generate transcripts and clinical notes that can be seamlessly stored in patients' electronic health records. Notetaker complements Tempus' existing mental health platform designed to support clinicians in delivering personalized care. It joins other precision medicine solutions, including the Tempus nP pharmacogenomic test and PRO™, the company's patient reported outcome solution. Key features of Notetaker include: Recording Sessions: Notetaker effortlessly transcribes and processes the session in real-time, capturing key details with precision, including specialized psychiatric terminology and medications. Generating Notes: At the end of each session, a clinical note is automatically created, highlighting essential information such as symptoms, progress, and action plans for quick review. Refining During Review: Clinicians can easily review and modify the autogenerated note using the Magic Edit features to adjust formatting or details according to their preferences. Care Gap Notification: Notetaker identifies and helps close care gaps with real-time pharmacogenomic insights for medications under consideration. "We are excited to enhance our mental health platform with Notetaker, a tool built by clinicians, for clinicians, and thoughtfully designed to meet the unique demands of psychiatric care," said Dr. Muneer Ali, Senior Director of Medical Affairs, Neurology and Psychiatry, at Tempus. "Notetaker eases the burden of clinical documentation, helping providers reclaim their time and streamline their workflow so they can focus on what matters most: their patients." Notetaker is capable of understanding more than 30 languages, including English, Spanish, and Chinese. It can seamlessly recognize language switching without the need to set a specific language in advance. With adjustable settings tailored for telehealth, in-person sessions, and dictation, Notetaker adapts to various environments for adequate audio capture. While providers are responsible for obtaining all necessary consents before recording sessions, Notetaker supports HIPAA-compliant data transfer and storage. To get started with Notetaker, please visit: For more information on Tempus' Neurology and Psychiatry platform, please visit: About Tempus Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended, about Tempus and Tempus' industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release are forward-looking statements, including, but not limited to, statements regarding the potential impact of Notetaker and other AI-solutions in supporting clinical care and administrative efficiency. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "going to," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," or "would" or the negative of these words or other similar terms or expressions. Tempus cautions you that the foregoing may not include all of the forward-looking statements made in this press release. You should not rely on forward-looking statements as predictions of future events. Tempus has based the forward-looking statements contained in this press release primarily on its current expectations and projections about future events and trends that it believes may affect Tempus' business, financial condition, results of operations and prospects. These forward-looking statements are subject to risks and uncertainties related to: Tempus' financial performance; the ability to attract and retain customers and partners; managing Tempus' growth and future expenses; competition and new market entrants; compliance with new laws, regulations and executive actions, including any evolving regulations in the artificial intelligence space; the ability to maintain, protect and enhance Tempus' intellectual property; the ability to attract and retain qualified team members and key personnel; the ability to repay or refinance outstanding debt, or to access additional financing; future acquisitions, divestitures or investments; the potential adverse impact of climate change, natural disasters, health epidemics, macroeconomic conditions, and war or other armed conflict, as well as risks, uncertainties, and other factors described in the section titled "Risk Factors" in Tempus' Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024 filed with the Securities and Exchange Commission ("SEC") as well as in other filings Tempus may make with the SEC in the future. In addition, any forward-looking statements contained in this press release are based on assumptions that Tempus believes to be reasonable as of this date. Tempus undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. View source version on Contacts Hanah Sign in to access your portfolio
Business Wire
05-05-2025
- Business
- Business Wire
Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an AI-powered clinical assistant to aid psychiatrists in generating progress notes. Notetaker, which is available in Tempus Hub, ambiently records patient sessions to generate transcripts and clinical notes that can be seamlessly stored in patients' electronic health records. Notetaker complements Tempus' existing mental health platform designed to support clinicians in delivering personalized care. It joins other precision medicine solutions, including the Tempus nP pharmacogenomic test and PRO™, the company's patient reported outcome solution. Key features of Notetaker include: Recording Sessions: Notetaker effortlessly transcribes and processes the session in real-time, capturing key details with precision, including specialized psychiatric terminology and medications. Generating Notes: At the end of each session, a clinical note is automatically created, highlighting essential information such as symptoms, progress, and action plans for quick review. Refining During Review: Clinicians can easily review and modify the autogenerated note using the Magic Edit features to adjust formatting or details according to their preferences. Care Gap Notification: Notetaker identifies and helps close care gaps with real-time pharmacogenomic insights for medications under consideration. "We are excited to enhance our mental health platform with Notetaker, a tool built by clinicians, for clinicians, and thoughtfully designed to meet the unique demands of psychiatric care," said Dr. Muneer Ali, Senior Director of Medical Affairs, Neurology and Psychiatry, at Tempus. "Notetaker eases the burden of clinical documentation, helping providers reclaim their time and streamline their workflow so they can focus on what matters most: their patients.' Notetaker is capable of understanding more than 30 languages, including English, Spanish, and Chinese. It can seamlessly recognize language switching without the need to set a specific language in advance. With adjustable settings tailored for telehealth, in-person sessions, and dictation, Notetaker adapts to various environments for adequate audio capture. While providers are responsible for obtaining all necessary consents before recording sessions, Notetaker supports HIPAA-compliant data transfer and storage. To get started with Notetaker, please visit: For more information on Tempus' Neurology and Psychiatry platform, please visit: About Tempus Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the 'Securities Act'), and Section 21E of the Securities Exchange Act of 1934, as amended, about Tempus and Tempus' industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release are forward-looking statements, including, but not limited to, statements regarding the potential impact of Notetaker and other AI-solutions in supporting clinical care and administrative efficiency. In some cases, you can identify forward-looking statements because they contain words such as 'anticipate,' 'believe,' 'contemplate,' 'continue,' 'could,' 'estimate,' 'expect,' 'going to,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' or 'would' or the negative of these words or other similar terms or expressions. Tempus cautions you that the foregoing may not include all of the forward-looking statements made in this press release. You should not rely on forward-looking statements as predictions of future events. Tempus has based the forward-looking statements contained in this press release primarily on its current expectations and projections about future events and trends that it believes may affect Tempus' business, financial condition, results of operations and prospects. These forward-looking statements are subject to risks and uncertainties related to: Tempus' financial performance; the ability to attract and retain customers and partners; managing Tempus' growth and future expenses; competition and new market entrants; compliance with new laws, regulations and executive actions, including any evolving regulations in the artificial intelligence space; the ability to maintain, protect and enhance Tempus' intellectual property; the ability to attract and retain qualified team members and key personnel; the ability to repay or refinance outstanding debt, or to access additional financing; future acquisitions, divestitures or investments; the potential adverse impact of climate change, natural disasters, health epidemics, macroeconomic conditions, and war or other armed conflict, as well as risks, uncertainties, and other factors described in the section titled 'Risk Factors' in Tempus' Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024 filed with the Securities and Exchange Commission ('SEC') as well as in other filings Tempus may make with the SEC in the future. In addition, any forward-looking statements contained in this press release are based on assumptions that Tempus believes to be reasonable as of this date. Tempus undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
Yahoo
01-05-2025
- Business
- Yahoo
Nylas Launches Notetaker API: Setting a New Standard for Embedded Meeting Intelligence
SAN FRANCISCO, May 01, 2025--(BUSINESS WIRE)--Nylas, the communications API platform trusted by thousands of developers worldwide, today announced the launch of its Notetaker API, a powerful new way to embed AI-powered meeting capture, transcription, and summarization into any application, with full calendar integration and built-in workflow automation. With Notetaker, developers can go far beyond basic call recording. The API is designed to help teams automatically capture, organize, and act on information from meetings — all while leveraging the broader Nylas platform to bring deep context and smart scheduling logic to every interaction. "The future of meetings isn't just about recording what happened — it's about making those insights instantly useful across your tools and workflows," said Christine Spang, CEO of Nylas. "With Notetaker, developers can deliver that experience out of the box while also leveraging our email, calendar, and contacts APIs." From Calendar to Call — and Beyond Notetaker is a developer-first solution built for modern productivity, sales, recruiting, and internal tools. Whether joining a meeting ad-hoc or through scheduled calendar events, the Notetaker API captures the full conversation — and delivers rich, structured data to power summaries, search, analytics, and automation. Key features include: Real-time transcription and speaker diarization powered by AssemblyAI Ad-hoc and scheduled meeting joins Secure audio and video recording (.WEBM) Event and calendar sync, enabling smart routing logic Automatic reschedule handling and meeting updates Flexible deployment as a standalone API or integrated with the Nylas platform By combining Notetaker with Nylas' Calendar API, developers can build experiences that automatically detect and join the right meetings — external vs. internal, 1:1s vs. team syncs — and trigger downstream workflows without manual configuration or constant oversight. Built for Builders The Notetaker API is available as both a standalone product and as part of the broader Nylas platform. This flexibility makes it easy for teams to get started quickly, while unlocking powerful functionality as they scale. Whether you're embedding meeting summaries into your product, building searchable knowledge hubs, or enabling smarter sales and recruiting workflows, Notetaker is designed to give developers everything they need — and nothing they don't. Get Started The Notetaker API is now available in public beta. Developers can get started today at: For media inquiries, demos, or early access to new capabilities, contact press@ About Nylas Nylas is a developer-first platform that helps teams build intelligent communications and scheduling features with ease. From calendar and email APIs to AI-powered tools like Notetaker, Nylas powers the infrastructure behind modern productivity and collaboration experiences. View source version on Contacts press@
Business Wire
01-05-2025
- Business
- Business Wire
Nylas Launches Notetaker API: Setting a New Standard for Embedded Meeting Intelligence
SAN FRANCISCO--(BUSINESS WIRE)--Nylas, the communications API platform trusted by thousands of developers worldwide, today announced the launch of its Notetaker API, a powerful new way to embed AI-powered meeting capture, transcription, and summarization into any application, with full calendar integration and built-in workflow automation. With Notetaker, developers can go far beyond basic call recording. The API is designed to help teams automatically capture, organize, and act on information from meetings — all while leveraging the broader Nylas platform to bring deep context and smart scheduling logic to every interaction. 'The future of meetings isn't just about recording what happened — it's about making those insights instantly useful across your tools and workflows,' said Christine Spang, CEO of Nylas. 'With Notetaker, developers can deliver that experience out of the box while also leveraging our email, calendar, and contacts APIs.' From Calendar to Call — and Beyond Notetaker is a developer-first solution built for modern productivity, sales, recruiting, and internal tools. Whether joining a meeting ad-hoc or through scheduled calendar events, the Notetaker API captures the full conversation — and delivers rich, structured data to power summaries, search, analytics, and automation. Key features include: Real-time transcription and speaker diarization powered by AssemblyAI Ad-hoc and scheduled meeting joins Secure audio and video recording (.WEBM) Event and calendar sync, enabling smart routing logic Automatic reschedule handling and meeting updates Flexible deployment as a standalone API or integrated with the Nylas platform By combining Notetaker with Nylas' Calendar API, developers can build experiences that automatically detect and join the right meetings — external vs. internal, 1:1s vs. team syncs — and trigger downstream workflows without manual configuration or constant oversight. Built for Builders The Notetaker API is available as both a standalone product and as part of the broader Nylas platform. This flexibility makes it easy for teams to get started quickly, while unlocking powerful functionality as they scale. Whether you're embedding meeting summaries into your product, building searchable knowledge hubs, or enabling smarter sales and recruiting workflows, Notetaker is designed to give developers everything they need — and nothing they don't. Get Started The Notetaker API is now available in public beta. Developers can get started today at: For media inquiries, demos, or early access to new capabilities, contact press@ About Nylas Nylas is a developer-first platform that helps teams build intelligent communications and scheduling features with ease. From calendar and email APIs to AI-powered tools like Notetaker, Nylas powers the infrastructure behind modern productivity and collaboration experiences.
